Picture EBD Group Biotech Showcase 2025 San Francisco BTS25 650x100px

Document › Details

AstraZeneca plc. (11/9/23). "Press Release: AstraZeneca Licenses Novel Agent for the Treatment of Cardiometabolic Conditions and Obesity [This press release is intended for investors and business / science media]".

	Region	ALL
	Organisation	Eccogene (CN)
	Product	ECC5005 (Eccogene / AstraZeneca)
	Product 2	obesity drug
	Index term	AstraZeneca–Eccogene: GLP-1 receptor agonist, 202311– license ww excl $185m upfront + $1.825b milestones + royalties for ECC5004
	Person	Zhou, Jingye (Eccogene 202311 CEO + Co-Founder before Lilly + GSK + Tetraphase Pharmaceutical)

Original document
accessed by [iito] on 2023-11-21

Record changed: 2024-03-14

Picture Consultech GmbH Secure Funding with RnD Grants 650x200px

More documents for AstraZeneca (Group)

[1] Amolyt Pharma SAS. (3/14/24). "Press Release: Amolyt Pharma Enters into Definitive Agreement to be Acquired by AstraZeneca. AstraZeneca Will Acquire Amolyt Pharma for up to $1.05 Billion in Total Consideration". Lyon & Cambridge, MA....
[2] Nanoform Finland Oyj. (10/23/23). "Press Release: Nanoform Grant Global Starmap AI License to AstraZeneca". Helsinki....
[3] Bico Group AB. (8/21/23). "Press Release: Maria Forss Is Appointed New President and CEO of Bico Group AB (publ)"....
[4] Capitainer AB. (1/30/23). "Press Release: Capitainer Announces Collaboration with AstraZeneca". Stockholm....
[5] Amolyt Pharma SAS. (1/6/23). "Press Release: Amolyt Pharma Announces $138 Million Series C Financing led by Sofinnova Partners and co-led by Intermediate Capital Group". Lyon & Cambridge, MA....
[6] Proteros Biostructures GmbH. (5/16/22). "Press Release: Proteros Expands Oncology Collaboration and License Agreement with AstraZeneca". Munich....
[7] Amolyt Pharma SAS. (9/16/21). "Press Release: Amolyt Pharma Announces $80 Million Series B Financing led by Sectoral Asset Management and Andera Partners". Lyon & Cambridge, MA....
[8] Proteros Biostructures GmbH. (6/2/21). "Press Release: Proteros Enters into Oncology Collaboration and License Agreement with AstraZeneca". Martinsried....
[9] Exscientia Ltd.. (11/10/20). "Press Release: Exscientia Recruits Industry Innovator Garry Pairaudeau as Chief Technology Officer"....
[10] Cellink AB. (8/27/20). "Press Release: Cytena and AstraZeneca Collaborate to Develop Plate Based Microbioreactors for Cell Line Development Workflows"....

To subscribe to our free, monthly newsletter for the European life sciences, please send an e-mail to info@iito.de and simply fill the subject line with the word »LSE Newsletter«

Find more infos about advertising at [iito] web portals in our media flyer [iito] in a Nutshell [PDF file]

Please visit also our web portals for the life sciences in German-speaking Europe (DE, AT & CH) and the worldwide mass spectrometry industry at Life-Sciences-Germany.com (life sciences in German-speaking Europe) and Mass-Spec-Capital.com (worldwide mass spectrometry)